Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 18, 2019
- Accepted June 4, 2019
- Published online July 19, 2019.
Article Versions
- Earlier version (June 5, 2019 - 11:21).
- Earlier version (June 18, 2019 - 08:46).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Maciej J. Zamek-Gliszczynski1,
- Xuexiang Zhang1,
- Jennypher Mudunuru,
- Yewei Du,
- Jian-Lu Chen,
- Kunal S. Taskar,
- Jane Huang,
- Yong Huang, and
- Elizabeth H. Romach
- GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
- Address correspondence to:
Dr. Maciej J. Zamek-Gliszczynski, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426. E-mail: maciej.x.zamek-gliszczynski{at}gsk.com